transplant trials in myeloma: emn02 and bmt ctn 0702
Published 6 years ago • 62 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
1:10
a trial investigating ibervd in transplant-ineligible newly diagnosed multiple myeloma
-
5:17
the evolving role of autologous transplantation in multiple myeloma
-
0:48
the role of transplant in myeloma
-
1:53
transplantation for consolidation in multiple myeloma
-
3:26
new approaches to treating transplant-ineligible multiple myeloma: triplets and quadruplets
-
5:24
the role of transplantation in the treatment of multiple myeloma
-
2:53
achieving functional cure in transplant-eligible and transplant-ineligible multiple myeloma
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
4:44
advances in the treatment of transplant-eligible and ineligible multiple myeloma
-
3:48
the current treatment landscape in multiple myeloma
-
2:44
second interim analysis of the emn02 trial
-
1:50
are we moving away from transplantation for the treatment of myeloma?
-
5:16
the evolution of al amyloidosis therapy
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
3:26
the challenges of transplantation for patients with multiple myeloma (mm)
-
1:33
the role of allogeneic transplantation in patients with multiple myeloma
-
2:10
phase ii study of epd maintenance after second autologous transplant for multiple myeloma
-
1:04
the value of mrd in transplant-ineligible patients with multiple myeloma
-
1:30
exploring the role of upfront autosct in multiple myeloma
-
1:45
evaluating nivolumab-based therapy to restore t-cell fitness in patients with r/r multiple myeloma
-
2:17
moving towards fixed-duration treatment in multiple myeloma
-
3:51
bmt ctn 1302: maintenance ixazomib following allohct in patients with high-risk myeloma